In this final excerpt from their new book, Morningstar's Heather Brilliant and Elizabeth Collins examine how companies can build competitive advantages around network effect and scale efficiency.
In this second excerpt from their new book, Morningstar's Heather Brilliant and Elizabeth Collins detail how companies leverage cost advantage and switching costs to their benefit.
In an excerpt from their new book, Morningstar's Heather Brilliant and Elizabeth Collins explore how to identify a moat and how intangible assets can help a firm carve out a sustainable competitive advantage.
Morningstar's 2013 CEO of the Year discusses his successful turnaround strategies and playbook for running a high-velocity railroad.
We recently launched a dedicated economic moat section in our Premium Stock Analyst Reports.
Morningstar's Heather Brilliant says investors could see a lot of market volatility this upcoming earnings season, but that could make for tremendous buying opportunities of quality names.
The market is still reasonably close to fair value, but we see some potentially deep shifts under the surface.
In an overall fairly valued market, it's time to be selective.
Morningstar recently upgraded several companies' moat ratings, and global equity research director Heather Brilliant explains why.
Morningstar's Heather Brilliant explains why investors should care about movement in market and sector correlations.
But even foreign-domiciled stocks can offer U.S. exposure, says Morningstar's Heather Brilliant.
Unless a company reports quarterly results that stray wildly from expectations, it's best to keep a long-term view on a stock, according to Morningstar's Heather Brilliant.
Morningstar CEO of the Year Pete Miller of National Oilwell Varco sees sustainable drilling prospects worldwide and expects the firm to use its expertise honed in the U.S. to take advantage of a global boom.
The environment is right for stock-picking to make a comeback.
A lot of companies are very well positioned regardless of how the fiscal cliff gets resolved, as long as it gets resolved, says Morningstar's Heather Brilliant.
Morningstar's Heather Brilliant says better revenue opportunities exist in the U.S. now than in foreign markets, and investors should demand discounts for firms with large non-U.S. sales footprints.
CEOs from three moat-worthy firms are in the running for this year's award.
Stocks look fairly valued, while the bond market continues to froth.
Morningstar's Heather Brilliant isn't optimistic about the market's--or Europe's--prospects for the rest of the year, though several stocks currently present buying opportunities.
Articulating your investing philosophy and then sticking with it can help investors avoid the mistakes that often arise with ad-hoc investing in the next big thing, says Morningstar's Heather Brilliant.
We expect opportunities will arise where strong companies with little exposure to Europe will get thrown out with the bathwater.
Over the long run, cheap wide-moat stocks have handily outperformed the market, says Morningstar's Heather Brilliant.
Morningstar's new Stewardship Ratings for stocks can help reveal if management teams are working in shareholders' best interests or just their own.
Our new rating system gets right to the heart of the matter: evaluating whether management teams are good stewards of shareholder capital.
New legislation will make it easier for startups to raise capital, but looser regulations on disclosure and research will make the IPO market less attractive for investors, says Morningstar's Heather Brilliant.
Morningstar's Heather Brilliant says the risk/reward profile for bonds is no longer in investors' favor, and stocks still offer better return potential despite the recent runup.
Following a global rally in the first quarter, opportunities are a lot more scarce than they were just three months ago.
Even if the economy is not off to the races, we think the stock market can do well in 2012.
As the risk of increasing inflation looms, the risk/reward opportunity in stocks does not signal a screaming buy to us at this point.
Management from these undervalued wide- and narrow-moat stocks will be presenting at our fifth annual event.
We've found a few more picks with home-run potential.
We see some compelling values in pharmaceuticals and medical devices.